Concepedia

Susan Light

SL

Statistics

Publications

19

Citations

2.5K

H-Index

17

Active since

1977

Affiliations

University of California, San Francisco(Current)

La Roche College

Medizinische Hochschule Hannover

Indiana University – Purdue University Indianapolis

University of Alabama at Birmingham

Susan Light is an author at University of California, San Francisco specializing in life sciences, immunotherapy, and transplant immunology.

Publications per year

1977–2016

19

Publications

19

Interleukin-2–Receptor Blockade with Daclizumab to Prevent Acute Rejection in Renal Transplantation

F. Vincenti, Robert L. Kirkman, Susan Light et al. · New England Journal of Medicine · 1998 · 876 citations · Full text

, , +17

REDUCTION OF ACUTE RENAL ALLOGRAFT REJECTION BY DACLIZUMAB1

Susan Light, Ian R. Hardie, Amy Lin et al. · Transplantation · 1999 · 308 citations

, , +17

Daclizumab, a humanized anti-interleukin-2 receptor alpha chain antibody, for treatment of acute graft-versus-host disease

Donna Przepiorka, Nancy A. Kernan, Cindy Ippoliti et al. · Blood · 2000 · 240 citations

, , +11

Daclizumab, a humanized anti-interleukin-2 receptor alpha chain antibody, for treatment of acute graft-versus-host disease

Donna Przepiorka, Nancy A. Kernan, Cindy Ippoliti et al. · Blood · 2000 · 238 citations

, , +11

A PHASE I TRIAL OF HUMANIZED ANTI-INTERLEUKIN 2 RECEPTOR ANTIBODY IN RENAL TRANSPLANTATION1

Flavio Vincenti, Marianne Lantz, Jytte L. Birnbaum et al. · Transplantation · 1997 · 147 citations

, , +17

1–5 of 19